Anti-Candida effect of bacillomycin D-like lipopeptides from Bacillus subtilis B38

FEMS Microbiology Letters

Volumn 316, Issue 2, 2011, Pages 108-114

  Tabbene, Olfa ^a   Kalai, Leila ^a   Ben Slimene, Imen ^a   Karkouch, Ines ^a   Elkahoui, Salem ^a   Gharbi, Abdelhamid ^b   Cosette, Pascal ^c   Mangoni, Maria Luisa ^d   Jouenne, Thierry ^c   Limam, Ferid ^a  

^a CENTRE DE BIOTECHNOLOGIE DE BORJ CÉDRIA   (Tunisia)

^b Laboratoire Régional de Santé Publique de Nabeul   (Tunisia)

^c UNIVERSITÉ DE ROUEN   (France)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anti Candida activity; Bacillus subtilis; Hemolysis; Lipopeptides; Peptide synthetases

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; BACILLOMYCIN D; BACILLOMYCIN D LIKE LIPOPROTEIN; ITURIN; LIPOPROTEIN; LONG CHAIN FATTY ACID; SURFACTIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; BACILLUS SUBTILIS; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOSYNTHESIS; CANDIDA ALBICANS; CONTROLLED STUDY; FINGER NAIL; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; HEMOLYSIS; LETTER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURIFICATION; SUPERNATANT;

ANTIFUNGAL AGENTS; BACILLUS SUBTILIS; CANDIDA ALBICANS; HEMOLYTIC AGENTS; HUMANS; LIPOPEPTIDES; PEPTIDES; SOIL MICROBIOLOGY;

BACILLUS SUBTILIS; CANDIDA; CANDIDA ALBICANS;

EID: 79951732269     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2010.02199.x     Document Type: Letter

References (37)

1. Aranda FJ, Teruel JA & Ortiz A (2005) Further aspects on the hemolytic activity of the antibiotic lipopeptide iturin A. Biochim Biophys Acta 1713: 51-56.
2. Avrahami D & Shai Y (2004) A new group of antifungal and antibacterial lipopeptides derived from non-membrane active peptides conjugated to palmitic acid. J Biol Chem 279: 12277-12285.
3. Besson F & Michel G (1984) Action of the antibiotics of the iturin group on artificial membranes. J Antibiot 37: 646-651.
4. Besson F & Michel G (1986) Isolation and characterization of new iturins: iturin D and iturin E. J Antibiot 39: 437-442.
5. Besson F, Peypoux F, Michel G & Delacambe L (1976) Characterization of iturin A in antibiotics from various strains of Bacillus subtilis. J Antibiot 29: 1043-1049.
6. Chen XH, Koumoutsi A, Scholz R, Schneider K, Vater J, Süssmuth R, Piel J & Borriss R (2009) Genome analysis of Bacillus amyloliquefaciens FZB42 reveals its potential for biocontrol of plant pathogens. J Biotechnol 140: 27-37.
7. Chung S, Kong H, Buyer JS, Lakshman DK, Lydon J, Kim SD & Roberts DP (2008) Isolation and partial characterization of Bacillus subtilis ME488 for suppression of soilborne pathogens of cucumber and pepper. Appl Microbiol Biotechnol 80: 115-123.
8. Hsieh FC, Li MC, Lin TC & Kao SS (2004) Rapid detection and characterization of surfactin-producing Bacillus subtilis and closely related species based on PCR. Curr Microbiol 49: 186-191.
9. Jerala R (2007) Synthetic lipopeptides: a novel class of anti-infectives. Expert Opin Inv Drug 16: 1159-1169.
10. Jutisz M (1960) Acides amines et peptides. La chromatographie en chimie organique et biologique, Vol. 2 (Lederer E, ed), pp. 373. Masson, Paris.
11. Kajimura Y, Sugiyama M & Kaneda M (1995) Bacillopeptins, new cyclic lipopeptide antibiotics from Bacillus subtilis FR-2. J Antibiot 48: 1095-1102.
12. Koumoutsi A, Chen XH, Henne A, Liesegang H, Hitzeroth G, Franke P, Vater J & Borriss R (2004) Structural and functional characterization of gene clusters directing nonribosomal synthesis of bioactive cyclic lipopeptides in Bacillus amyloliquefaciens strain FZB42. J Bacteriol 186: 1084-1096.
13. Kracht M, Rokos H, Özel M, Kowall M, Pauli G & Vater J (1999) Antiviral and hemolytic activities of surfactin isoforms and their methyl ester derivatives. J Antibiot 52: 613-619.
14. Maget-Dana R & Peypoux F (1994) Iturins, a special class of pore-forming lipopeptides: biological and physicochemical properties. Toxicology 87: 151-174.
15. Maget-Dana R & Ptak M (1995) Interactions of surfactin with membrane models. Biophys J 68: 1937-1943.
16. Malina A & Shai Y (2005) Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of cationic biologically inactive peptide. Biochem J 390: 695-702.
17. Mangoni ML, Rinaldi AC, Di Giulio A, Mignogna G, Bozzi A, Barra D & Simmaco M (2000) Structure-function relationship of temporins, small antimicrobial peptides from amphibian skin. Eur J Biochem 267: 1447-1454.
18. Moyne AL, Shelby R, Cleveland TE & Tuzun S (2001) Bacillomycin D: an iturin with antifungal activity against Aspergillus flavus. J Appl Microbiol 90: 622-629.
19. Naeini A, Khosravi AR, Chitsaz M, Shokri H & Kamlnejad M (2009) Anti-Candida albicans activity of some Iranian plants used in traditional medicine. J Mycol Méd 19: 168-172.
20. 2, produced by Bacillus cereus BMG302-fF67. III. Structural elucidation of plipastatins. J Antibiot 39: 755-761.
21. Oleinikova GK, Dmitrenok AS, Voinov VG, Chaikina EL, Shevchenko LS & Kuznetsova TA (2005) Bacillomycin D from the marine isolate of Bacillus subtilis KMM 1922. Chem Nat Compd 41: 461-464.
22. Onishi J, Meinz M, Thompson J et al. (2000) Discovery of novel antifungal (1, 3)-β-d-glucan synthase inhibitors. Antimicrob Agents Ch 44: 368-377.
23. Peypoux F, Besson F, Michel G & Delcambe L (1981) Structure of bacillomycin D, a new antibiotic of the iturin group. Eur J Biochem 118: 323-327.
24. Peypoux F, Pommier MT, Das BC, Besson F, Delcambe L & Michel G (1984) Structures of bacillomycin D and bacillomycin L peptidolipid antibiotics from Bacillus subtilis. J Antibiot 37: 1600-1604.
25. Pirri G, Giuliani A, Nicoletto SF, Pizzuto L & Rinaldi AC (2009) Lipopeptides as anti-infectives: a practical perspective. Cent Eur J Biol 4: 258-273.
26. Prokof'eva NG, Kalinovskaya NI, Luk'yanov PA, Shentsova EB & Kuznetsova TA (1999) The membranotropic activity of cyclic acyldepsipeptides from bacterium Bacillus pumilus, associated with the marine sponge Ircinia sp. Toxicon 37: 801-813.
27. Quentin MJ, Besson F, Peypoux F & Michel G (1982) Action of peptidolipidic antibiotics of the iturin group on erythrocytes: effect of some lipids on hemolysis. Biochim Biophys Acta 684: 207-211.
28. Ramarathnam R, Bo S, Chen Y, Dilantha Fernando WG, Xuewen G & De Kievit T (2007) Molecular and biochemical detection of fengycin and bacillomycin D producing Bacillus spp., antagonistic to fungal pathogens of canola and wheat. Can J Microbiol 53: 901-911.
29. Russell DW (1960) Ninhydrin as a reagent for N-methyl amino acids. J Chromatogr 4: 251-252.
30. Stein T (2005) Bacillus subtilis antibiotics: structure, syntheses and specific functions. Mol Microbiol 56: 845-857.
31. Strieker M & Marahiel MA (2009) The structural diversity of acidic lipopeptide antibiotics. ChemBiochem 10: 607-616.
32. Tabbene O, Ben Slimene I, Bouabdallah F, Mangoni ML, Urdaci MC & Limam F (2009) Production of anti-methicillin-resistant Staphylococcus activity from Bacillus subtilis sp. strain B38 newly isolated from soil. Appl Biochem Biotech 157: 407-419.
33. Vollenbroich D, Özel M, Vater J, Kamp RM & Pauli G (1997a) Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis. Biologicals 25: 289-297.
34. Vollenbroich D, Pauli G, Ozel M & Vater J (1997b) Antimycoplasma properties and application in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilis. Appl Environ Microb 63: 44-49.
35. Volpon L, Tsan P, Majer Z, Vass E, Hollósi M, Noguéra V, Lancelin JM & Besson F (2007) NMR structure determination of a synthetic analogue of bacillomycin Lc reveals the strategic role of L-Asn1 in the natural iturinic antibiotics. Spectrochim Acta A 67: 1374-1381.
36. Yu GY, Sinclair JB, Hartman GL & Bertagnolli BL (2002) Production of iturin A by Bacillus amyloliquefaciens suppressing Rhizoctonia solani. Soil Biol Biochem 34: 955-963.
37. Zarif L, Graybill JR, Perlin D, Najvar L, Bocanegra R & Mannino RJ (2000) Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model. Antimicrob Agents Ch 44: 1463-1469.